Publications
- Erlotinib in the treatment of advanced non-small cell lung cancer - present experience and results in the Czech Repuiblic2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Monitoring of the expensive pneumooncological first-line treatment of the advanced non-small cell lung cancer in the TULUNG register in the Czech Republic2017 | Faculty of Medicine in Pilsen, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Léčba nemalobuněčného karcinomu plic Xalkori2017 | Publication without faculty affiliation
- Monoclonal antibodies in the treatment of non-small cell lung carcinoma2017 | Publication without faculty affiliation
- Continuation maintenance therapy with pemetrexed in patients with non-small-cell lung cancer in the Czech Republic2016 | First Faculty of Medicine
- Immunotherapy in treatment of lung cancer2016 | Publication without faculty affiliation
- Pembrolizumab in the treatment of non-small-cell lung cancer2016 | Publication without faculty affiliation
- Present and new trends in the treatment of non-small cell lung cancer2016 | Publication without faculty affiliation
- New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic2012 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
- Efficiency and safety of pemetrexed and cisplatin therapy in the adenocarcinoma and large cell cancer types of advanced non-small cell lung cancer (NSCLC)2012 | Publication without faculty affiliation
Loading network view...